Differentiation between a relapse or late reversal reaction foliowing completion of regular drug therapy in patients with leprosy is often difficult, though it has definite therapeutic implications. The present case documents a late reversal reaction occurring an unusually long time after the completion of multi-drug therapy.
Nerve damage in active leprosy is a reflection of cellular immune response to mycobacterial antigen. Whereas the dermal lesions of leprosy affect patients cosmetically, it is the neural damage and the resultant deformities which serve as constant reminders of the disease. The introduction of multi-drug therapy has brought new hope to the management of leprosy. However, exacerbations of the disease are reported at variable times following completion of therapy. Distinguishing relapse from a reaction is often difficult on clinical grounds and sometimes even after bacteriologic and histopathologic investigation. This is particularly true in paucibacillary disease. 1 Such exacerbations, attributed to increases in the leprosy antigen, have been well recognised up to two years after completion of treatment in paucibacillary and up to five years in multibacillary leprosy.2 We report a case that illustrates how leprosy antigen may cause reversal reactions as late as 10 years after completion of multi-drug therapy.
Case report
A 35-year-old man with borderline Hansen's disease received World Health Organisation multi-drug therapy for two years from 1983. The diagnosis and classification of leprosy was based on clinical and histopathological features of skin lesions and demonstration of acid-fast bacilli on slit and scrape skin smear. There was no neurological deficit, although the nerve trunks were enlarged and tender. Regular therapy led to complete clearance of skin lesions and he remained symptom-free for 10 years. Thereafter, he complained of numbness and paraesthesiae in both hands rapidly progressing to both lower limbs as well. This was followed over the next three weeks by fever, malaise and the rapid development of weakness in both feet and hands over three days. He did not give any history of recent major illness nor any drug therapy for these symptoms. He did not have clinical indicators of immunosuppression nor had he received recent blood transfusion. Examination revealed a slim young man with no skin lesions. Neurological findings were confined to the limbs. He had bilateral foot drop with clawing and distal amyotrophy of both hands. There was glove and stocking hypo-aesthesiae for touch, pain and temperature, relatively more marked over the distribution of ulnar and peroneal nerves bilaterally. Deep tendon reflexes were normal and the plantars were equivocal. Ulnar and peroneal nerves of both sides were thickened and were markedly tender.
The slit and smear examination did not show any acid-fast bacilli (AFB). Full blood count and blood biochemistry for sugar, creatinine, liver functions were normal. The motor nerve conduction study revealed inexcitable median, ulnar and peroneal nerves on both sides. No sensory nerve action potentials could be recorded along these nerves. Biopsy of the sural nerve showed dense mononuclear cell infiltration of the nerve fascicles with perineural fibrosis. No foamy histiocytic cells were seen. Perivascular lymphocytic infiltrates were present (figure). The slides stained for AFB were negative.
The patient was diagnosed as having a reversal reaction and was kept on prednisolone 60 mg/day for one week, then tapered off over a period of six weeks. His sensory symptoms rapidly subsided and the foot drop improved remarkably. However, the clawing of the hands and hypo-aesthesia along the distribution of ulnar and peroneal nerves persisted. A repeat nerve conduction study after an interval of 
